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Three Schiff base ligands which contain N2O2 donors and their oxo-vanadium(IV) complexes have been synthesized. 
The ligand C14H16N2O2 has obtained as a result of the reaction of 1,4-diaminobutane with 2-furan-carboxyaldehyde within 
the framework of Schiff base condensation method. The same reaction path is followed replacing 1,4-diaminobutane by 1,6-
diaminohexane and 1,8-diaminooctane in separate reactions to obtain the two other new ligands. Then, the synthesized 
ligands are employed to attain the oxo-vanadium(IV) complexes as results of their reactions with VOSO4.H2O. The ligands 
have been characterized by FTIR, 13C NMR, 1H NMR, and LC/ESI-MS. The VO(IV) complexes have been elucidated by 
FTIR, LC/ESI-MS, energy dispersive X-ray spectroscopy, thermogravimetric methods, and the conductivity and magnetic 
susceptibility measurements. The antibacterial activities of the ligands and their complexes have been determined on the 
microorganisms which are aligned as Escherichia coli ATCC 25922, Salmonella typhimurium ATCC 14028, 
Staphylococcus aureus ATCC 25923, Listeria monocytogenes ATCC 19115 and Bacillus cereus ATCC 11778. The 
complexes, in general, appeared to be more active than their parent ligands. All the activities can be classified as moderate  
in comparison with the corresponding antibiotic effect on the same bacteria. 
Keywords: Schiff base, Antibacterial activity, Oxo-vanadium(IV) complexes, Furan 
The Schiff base ligand and their generally stable 
metal complexes have wide application fields in 
industrial and clinical research. Some of these metal 
complexes are employed in dye and textile industries, 
polymer technology and electronic industry
1-7
 as well 
as in medicinal and agricultural research due to their 
high biological activity
8,9
. As a sub-class of the Schiff 
base molecules, the furan-derived ligand complexes 
with metals have been subjected to studies such as 
their optical properties and the usage of them as 
sensors in biomedical research
10,11
. Research has 
shown that vanadium complexes have potential of 
applications such as their antitumor, antibacterial, 
antiviral and antiparasitic effects
12-16
, while they also 
show antidiabetic properties which are similar to that 
of insulin. Therefore, they attract attention in clinic, in 
vivo and in vitro studies which are carried out to 
explore alternative chemicals to insulin in the 
treatment of diabetes. Also, the furan-derived Schiff 
base ligands and oxovanadium(IV) complexes have a 
special importance in the search of antidiabetics
17
. 
The three ligands containing N2O2 donors were 
synthesized by Schiff base condensation of the 
aromatic aldehyde 2-furan-carboxyaldehyde with 
three different diamines which are 1,4-diaminobutane, 
1,6-diaminohexane and 1,8-diaminooctane, respectively. 
1,4-diaminobutane was studied and used to build 
ruthenium complexes, earlier
18
. The other two, i.e., 
1,6-diaminohexane and 1,8-diaminooctane are newly 
synthesized to the best of our knowledge. These 
ligands were used to obtain three different tetra 
dentate vanadium complexes. The structures of 
synthesized ligands were identified by FTIR, 
13
C-
NMR, 
1
H-NMR, LC/ESI-MS as those of oxo-
vanadium(IV) complexes were elucidated by FTIR, 
energy dispersive x-ray spectra (EDX), 
thermogravimetric (TG) analysis, differential thermal 
analysis (DTA), conductivity and magnetic 
measurements. Also, the antibacterial activities of the 
ligands and complexes were studied in detail. 
 
Materials and Methods 
Instruments 
The FTIR spectra were acquired within the range 
450−4000 cm−1 by a Perkin-Elmer spectrometer.  
The 
1
H NMR and 
13
C NMR spectra of the compounds 
were recorded on Varian 300 MHz and Varian  
75.5 MHz, respectively. The mass spectra of ligands 
ULUCAM & YENTURK: VO(IV) COMPLEXES OF N2O2 TETRADENTATE LIGANDS 
 
 
527 
and complexes were recorded in the Agilent 
Technologies 6460 Triple Quad LC/ESI-MS device. 
The thermogravimetric measurements were made in 
the temperature range of 20−1200 °C with the heating 
rate of 10 °C min
−1
 under nitrogen atmosphere (20 mL 
min
−1
) by a Seiko SII TG-DTA 6300-TG/DTA 
analyzer. The chemical composition has been 
determined by EVO LS 10 model Electron Microscope 
(SEM-TEM-EDX). The biological activities of  
the the ligands and their oxo-vanadium complexes 
were realized by absorbance measurements in  
thermoscientific multiscan Go multi-plate 
spectrophotometer. The solid-state magnetic 
susceptibility data were recorded on powdered 
microcrystalline samples using a Sherwood Scientific 
Magnetic Susceptibility Balance. The molar 
conductivities were measured using a Jenco 3173 
Conductivity Meter.  
 
Synthesis of Furan-derived Schiff Base Ligands  
The synthesis of the ligands is shown in Scheme 1. 
In details, 1,4-diaminobutane (0.44 g, 5 mmol) was 
dissolved in 20 mL of methanol to prepare 
C14H16N2O2 (L1). 2-furan-carboxaldehyde (0.96 g,  
10 mmol) was weighed and dissolved by adding  
25 mL methanol in a different container. The solution 
was heated and mixed by adding the aldehyde 
solution slowly within an hour. A few drops of glacial 
acetic acid were added to the mixture to ease the 
reaction. It was refluxed monitoring the reaction with 
thin-layer chromatography using (1:1) ethylacetate: 
hexane solvent. Then, the methanol was removed 
using a rotary evaporator. The end-product was dried 
in vacuum oven. The dark brown colored and viscose 
L1 (0.97 g, 80%) was obtained. 
The above procedure was repeated twice using  
1,6-diaminohexane (0.58 g, 5 mmol) and 1,8- 
diaminooctane (0.72 g, 5 mmol) instead of 1,4-
diaminobutane (0.44 g, 5 mmol), respectively.  
The ligands C16H20N2O2 (L2) (1.03 g, 78%)  
and C18H24N2O2 (L3) (0.99 g, 83%) were obtained  
in viscous brown colored form.  
 
Synthesis of oxo-vanadium(IV) complexes 
The formation of the complexes is shown in 
Scheme 2. First, L1 (0.244 g, 1 mmol) was diluted in 
20 mL methanol while heated at the same time. Then, 
VOSO4.H2O salt (0.163 g, 1 mmol) was dissolved in 
20 mL methanol and added dropwise to the L1 
solution within an hour. The mixture was refluxed  
for 2 days and left for a few days to obtain its solid 
form. The L1-VO(IV) complexes were filtered and 
washed with methanol. Finally, it was dried in a 
vacuum oven.  
The above procedure was repeated twice using L2 
and L3 instead of L1. All the complexes L1-VO(IV), 
L2-VO(IV) and L3-VO(IV) were green in powder 
form.They were weighted 0.16 g, 0.17 g and 0.50 g 
with the yields 52%, 50% and 40%, respectively. We 
did not obtain the complexes in their crystalline 
forms. 
 
Antibacterial activities  
The Broth Micro dilution method by Clinic 
Laboratory Standards Institute (CLSI) was used to 
determine antibacterial efficiency of the ligands and 
the complexes. The bacteria tested were Escherichia 
coli ATCC 25922, Staphylococcus aureus ATCC 
25923, Listeria monocytogenes ATCC 19115, 
Salmonella typhimurium ATCC 14028, and Bacillus 
cereus ATCC 11778. These microorganisms were 
incubated in Tryptic Soy Broth (TSB) at 37 °C for  
24 and 48 h. The McFarland scale was fixed to 0.5 in 
determination of the cell concentrations. The 
antibiotic control was provided by the commercially 
available ampicillin. All the solutions were filtered 
through 0.45 μm sterile filters. The substance 
concentrations were 200, 100, 50, 25, 12.5 and 6.25 in 
the units of μg/mL. Starting from 200 µg/mL stock 
solutions, the concentrations were obtained diluting 
each concentration in half. All the microplates were 
incubated at 37 °C for 24 and 48 h. The sterility and 
 
 
Scheme 1 
 
 
 
Scheme 2 
INDIAN J CHEM, SEC A, APRIL 2020 
 
 
528 
the growth controls were realized by the pure 
chemical substance embedded wells for each 
concentration and the pure bacteria planted wells, 
respectively. The percentage viabilities were 
determined by measuring the absorbance values at 
600 nm
19,20
. 
 
Result and discussion 
The ligands  
The ligands L1, L2 and L3 which were synthesized 
by using Schiff base condensation method were 
enlightened by FTIR, 
13
C NMR, 
1
H NMR, and 
LC/ESI-MS analysis. 
 
FTIR results 
The selected FTIR features for the synthesized 
ligands were L1- νmax (cm
−1
): 2966−2923 (C-H), 1660 
(C=N), 1250 (C-O); L2- νmax (cm
−1
): 2929−2854     
(C-H), 1643 (C=N), 1238 (C-O), L3- νmax (cm
−1
): 
3043−2924 (C-H), 1624 (C=N), 1260 (C-O). 
The C-H vibrations at 3000±45 cm
-1
, C=N 
vibrations at 1642±48 cm
−1
 and C-O vibrations at 
1249±19 cm
−1
 for L1, L2, and L3 ligands, 
respectively are in agreement with the previous 
measurements
21
. The typical starting material signals 
represented by N-H vibrations of primary amines 
(3500−3300 cm−1) and C=O vibration of aldehyde 
(1750 cm
−1
) have been absent in all the three spectra. 
This indicates that H-N-H and C=O groups in the 
starting chemicals ended up as C=N groups in the 
final products, as expected.  
 
NMR results 
The 
1
H NMR and 
13
C NMR spectra results for the 
ligands are as follows: L1-δH (300 MHz; CDCl3): 
1.65−1.71 (2H, m, CH2), 3.52 (2H, t, CH2), 6.37  
(1H, t, CH), 6.63 (1H, d, CH), 7.41 (1H, d, CH),  
7.98 (1H, s, CHN), L2-δH (300 MHz; CDCl3): 
1.35−1.38 (2H, m, CH2), 1.69−1.70 (2H, m, CH2), 
3.56 (2H, t, CH2), 6.43 (1H, t, CH), 6.67 (1H, d, CH), 
7.47 (1H, d, CH), 8.04 (1H, s, CHN), L3-δH  
(300 MHz; CDCl3): 1.170−1.173 (4H, m, CH2), 
1.53−1.56 (2H, m, CH2), 3.92 (2H, t, CH2), 6.28  
(1H, t, CH), 6.55 (1H, d, CH), 7.32 (1H, d, CH),  
7.89 (1H, s, CHN), L1-δC (75.5 MHz; CDCl3):  
28.62 (CH2), 61.68 (CH2), 111.74, 114.08,  
144.80 (CH), 149.88 (C), 151.62 (CHN), L2-δC  
(75.5 MHz; CDCl3): 27.34 (CH2), 30.99 (CH2),  
62.04 (CH2), 111.75, 113.94, 144.80 (CH), 149.65 
(C), 151.76 (CHN), L3-δC (75.5 MHz; CDCl3): 27.32 
(CH2), 29.40 (CH2), 30.87 (CH2), 61.88 (CH2), 
111.64, 113.79, 144.59 (CH), 149.49 (C),  
151.59 (CHN). 
The integration of CH2 multiplet of L1 in 1.65−1.71 
ppm interval gives two hydrogens. The two multiplets 
which belong to L2 in 1.35−1.38 ppm and 1.69−1.70 
ppm intervals content four hydrogens. Also, the  
two multiplets of L3 in 1.170−1.173 ppm and 
1.53−1.56 ppm intervals contain six hydrogens. This 
increase in the hydrogen numbers from L1 to L3 is due 
to the increase of CH2 number in the bridge between 
two furans. The NMR signals of the other symmetrical 
CH2 protons and aromatic protons and CHN protons 
have granted the common properties of the three 
ligands as the measurements of these signals are  
self-consistent. The different and common properties of 
the ligands determined by 
1
H NMR spectra repeated by 
the 
13
C NMR spectra as the number of carbons are 
identified as expected for each ligand. Additionally, the 
CH2 carbons, aromatic carbons and CHN carbons have 
consistent NMR signals. 
 
Mass spectra results 
The mass spectra of L1, L2 and L3 are given in 
Supplementary Data, Figs S1a, S1b and S1c, 
respectively. LC/ESI-MS data for the ligands L1 (m/z) 
[M+H]
+
: 245.1000, L2 (m/z) [M+H]
+
: 273.2000 and 
L3 (m/z) [M+H]
+
: 301.2000 were in agreement with 
the calculated molecular weights.  
 
The oxo-vanadium(IV) complexes 
The complexes L1-VO(IV), L2-VO(IV) and  
L3-VO(IV) were synthesized by the reaction of  
Schiff base ligands with VOSO4.H2O
21,11
. The 
structures of the obtained oxo-vanadium(IV) 
complexes are clarified by FTIR, LC/ESI-MS, EDX 
spectra, thermal analysis, conductivity and magnetic 
moment measurements. 
 
FTIR results 
The FTIR spectrum of L1-VO(IV) presents specific 
C=N stretching at 1622 cm
−1
. Almost identically,  
L2-VO(IV) and L3-VO(IV) show the same 
stretchings at 1624 cm
−1
 and 1622 cm
−1
. The other 
characteristic vibrations supporting their proposed 
structures of the complexes L1-VO(IV), L2-VO(IV) 
and L3-VO(IV) are ν(V=O) stretchings at 962, 956 
and 968 cm
−1
, respectively. Also, the ν(V-N) 
stretchings at 595, 611 and 598 cm
−1
 and ν(V-O) 
vibrations at 485, 477 and 480 cm
−1
 for L1-VO(IV), 
L2-VO(IV) and L3-VO(IV) supports the constitution 
of the complexes
22,23
. 
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LC/ESI-MS results 
The LC/ESI-MS data of L1-VO(IV) in 
Supplementary Data, Fig. S2a showed a molecular ion 
peak at (m/z) [M
•+
]: 311.2000 as radical cation, while 
this figure is 311.2 as its calculated molecular weight. 
The mass spectra of L2-VO(IV) shows in 
Supplementary Data, Fig. S2b gives (m/z) [M
•+
]: 
339.1000 (calculated 339.3) while that of L3-VO(IV) 
gives (m/z) [M
•+
]: 366.9000 (calculated 367.3) in 
Supplementary Data, Fig. S2c. All the mass spectra 
results have been in agreement with the predicted 
molecular weights. 
 
EDX results 
The EDX elemental analysis results by percentage 
weight were as follows: L1-VO(IV): (w%)  
C 41.81(6.10), N 7.69(2.35), O 32.86(4.91),  
S 5.58(0.27), V 12.06(0.30), L2-VO(IV): (w%)  
C 41.90(5.90), N 8.06(2.33), O 30.49(4.56),  
S 6.99(0.32), V 12.56(0.30), L3-VO(IV): (w%)  
C 46.06(6.30), N 7.13(1.74), O 31.59(3.67),  
S 5.30(0.19), V 9.92(0.27). These experimental 
results are in agreement with the calculated 
percentage weights of the complexes. Their EDX 
spectra are shown in Figs 1(a, b and c) for  
L1-VO(IV), L2-VO(IV) and L3-VO(IV), 
respectively. The peaks corresponding to V, C, S,  
N and O elements observed in the energy dispersive 
spectra were in accord with the previous 
measurements on the similar materials
24,25
. The 
presences of vanadium peaks in the spectra support 
the formation of the complexes. The quantitative 
existence of the sulfur and oxygen in the EDX spectra 
shows that SO4.2H2O is in the structure as the counter 
ion of the vanadium oxide-ligand complex. 
 
TG analysis 
The TG and DTA plots for L1-VO(IV), L2-VO(IV) 
and L3-VO(IV) are shown in Figs 2(a, b and c), 
respectively. The decomposition processes can be 
described as presenting three stage occurrences in the 
all complexes. For the L1-VO(IV), the first stage 
decomposition takes place in the temperature range of 
25−150 °C. It reflects a mass loss of 10.0% 
(calculated 8.1%) which corresponds to the two moles 
of water. The second and third stages of the 
decomposition observed in the temperature range 
150−550 °C in where the organic parts and the SO4 
removed from the structure with a mass loss of 72.0% 
(calculated 73.2%). The remaining residue was 18.0% 
(calculated 18.7%) vanadium dioxide. The water loss 
of the L2-VO(IV) and L3-VO(IV) are 9.0% 
(calculated 7.6%) and 7.0% (calculated 7.2%), 
respectively in 25-150 °C range. These decomposition 
rates are similar to that of the L1-VO(IV). The 
decomposition of sulfate ion and the organic parts in 
L2-VO(IV) were 72.0% (calculated 74.9%) in the 
150−600 °C against that of L3-VO(IV) 76.0% 
(calculated 76.2%) in the temperature range of 
150−530 °C. The second and third decomposition of 
the complexes under nitrogen were symbolized by the 
exothermic peaks in the DTA for the all complexes 
are shown in Figs 2a–2c. The vanadium dioxide 
residues of L2-VO(IV) and L3-VO(IV) were 19.0% 
(calculated 17.5%) and 17.0% (calculated 16.5%), 
respectively. The TG–DTA curves of the VO(IV) 
complexes are very similar to each other supporting 
 
Fig. 1 ― EDX spectra of the complexes (a) L1-VO(IV), (b) L2-
VO(IV) and (c) L3-VO(IV). 
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the constitution of the complexes. The thermal 
stability of complexes, based on the temperature at 
which the third mass loss stage ends, follows the 
order L3-VO(IV) < L1-VO(IV) < L2-VO(IV). 
Conductivity and magnetic susceptibility  
The molar conductivities and the magnetic 
moments of the complexes are presented in Table 1. 
While the magnetic moment of the coordination 
compound is useful in determining the valence of the 
metal atom and in many cases defining the geometric 
structure of a complex, conductivities illuminate the 
electrolytic nature of the complexes. 
The conductance measurements were carried out 
for 1 mmol DMF solutions of the complexes at 25 °C. 
The high molar conductivity values of the complexes 
determined in the 78–80 −1 cm2 mol−1 range  
show that all three complexes were established as  
1:1 electrolyte
26-28
.  
In determination of their geometrical structure, the 
magnetic susceptibilities of the solid-state complexes 
under discussion were measured by the Gouy balance 
method. The magnetic moment values measured in 
the range of 1.71−1.74 BM at room temperature were 
compatible to the reported magnetic moments for the 
square-pyramidal geometry. It is the fact that they are 
well suited for oxo-vanadium(IV) complexes having a 
single unpaired electron
29-31
. 
 
Antibacterial activities of ligands and complexes  
The antibacterial activities for both the ligands and 
complexes are presented in Table 2. The viability 
percentages were given for the 200 µg/mL dose 
application including the antibiotic control on the 
bacteria. The incubation time allowed for each 
bacteria sample were 48 h.  
Apparently the complexes probably due to their 
oxo-vanadium ion are more active than their parent 
ligands, and these activities can be classified 
moderate in terms of the antibiotic effects on the 
Table 2 ― Antibacterial activity of the ligands and complexes in units of percentage viability for 200 µg/mL dose as  
compared with the activity of standard ampicillin 
Viability (%) L1/ L1VO(IV) L2/ L2VO(IV) L3/ L3VO(IV) Ampicillin 
Escherichia coli ATCC 25922 105 / 105 105 / 100 109 / 85 11 
Salmonella typhimurium ATCC 14028 114 / 108 111 / 101 121 / 110 24 
Staphylococcus aureus ATCC 25923 115 / 75 103 / 68 113 / 90 31 
Listeria monocytogenes ATCC 19115 108 / 68 110/ 75 98 / 73 10 
Bacillus cereus ATCC 11778 109 / 50 107 / 65 108 / 55 33 
 
 
Fig. 2 ― TG-DTA spectra of the complexes (a) L1-VO(IV), (b) 
L2-VO(IV) and (c) L3-VO(IV). 
Table 1 ― Conductivity and magnetic moments of  
oxo-vanadium(IV) complexes 
Complex μeff (BM) ΩM (Ω
−1cm2mol−1) 
L1-VO(IV) 1.72 78 
L2-VO(IV) 1.74 80 
L3-VO(IV) 1.71 79 
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bacteria. The L1-VO(IV), L2-VO(IV) and L3-VO(IV) 
were active on Bacillus cereus ATCC 11778 with 
50%, 65%, and 55% viability, respectively. These 
figures show quite a high efficiency of the complexes 
on the latter bacteria if they are compared with the 
antibiotic viability 33% on the same bacteria. 
 
Conclusions 
The three Schiff base ligands L1, L2 and L3  
were synthesized by condensation of 2-furan-
carboxaldehyde with the diamines, namely 1,4 
diaminobutane, 1,6 diaminohexane and 1,8 
diaminooctane, respectively. Afterwards, these 
ligands were separately reacted with VO(SO4).H2O to 
obtain the L1-VO(IV), L2-VO(IV) and L3-VO(IV) 
complexes. The 
1
H NMR results have shown that both 
the aliphatic proton resonances of the ligands and the 
proton resonances of their aromatic rings together 
with the singlets of the imine protons were found as 
expected and in accord with the concerning studies. 
The range of the aliphatic, the aromatic ring and the 
imine carbon resonances were also consistent with the 
previous studies supporting the existence of the 
predicted ligand structures. The structure of the 
ligands was also confirmed by FTIR and mass 
spectra. In the FTIR spectra of the ligands, the 
vibrations of the starting materials such as primary 
amine and aldehyde are not observed, and the imine 
vibrations occurring in their place are evidence of the 
robust synthesis of the ligands. Additionally, the 
molecular ion peaks and degradation products 
observed in the mass spectra have been consistent 
with the molecular structure of the ligands.  
These syntheses of the complexes have been 
validated by the ν(V=O), ν(V-O) and ν(V-N) 
vibrations which are the characteristic peaks of the 
concerning bonds in their FTIR spectra. The existence 
of V, C, S, N and O are observed in the energy 
dispersive x-ray spectra. The thermal analysis results 
show that the ligands coordinate the vanadium ion 
with their nitrogens of imines and oxygens of furan. 
The high molar conductance of oxovanadium(IV) 
complexes reflects their electrolytic nature and the 
measured magnetic moment values of complexes 
suggest a square-pyramidal geometry. Finally, the 
oxovanadium(IV) complexes have been found to have 
stronger influence on the selected bacteria in 
comparison with those of furan-derived ligands. The 
activities of complexes on Bacillus cereus ATCC 
11778 have the antibiotic equivalent effect. 
Supplementary Data 
Supplementary Data associated with this  
article are available in the electronic form at: 
http://nopr.niscair.res.in/jinfo/ijca/IJCA_59A(04)526-
532_SupplData.pdf. 
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